Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Ratiu

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Diabetes|March 11, 2016
B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD miceCaroline M Leeth, Jeremy Racine, Harold D Chapman, et al.
Diabetes|February 24, 2018
Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy DevelopmentJeremy J Racine, Isabel Stewart, Jeremy Ratiu, et al.
Nature Communications|October 30, 2022
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastomaWilliam H Tomaszewski, Jessica Waibl-Polania, Molly Chakraborty, et al.
Cell Host & Microbe|January 5, 2023
Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetesMatthew C Funsten, Leonid A Yurkovetskiy, Andrey Kuznetsov, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Diabetes|March 11, 2016
B-lymphocytes expressing an Ig specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD miceCaroline M Leeth, Jeremy Racine, Harold D Chapman, et al.
Diabetes|February 24, 2018
Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy DevelopmentJeremy J Racine, Isabel Stewart, Jeremy Ratiu, et al.
Nature Communications|October 30, 2022
Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastomaWilliam H Tomaszewski, Jessica Waibl-Polania, Molly Chakraborty, et al.
Cell Host & Microbe|January 5, 2023
Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetesMatthew C Funsten, Leonid A Yurkovetskiy, Andrey Kuznetsov, et al.
NPJ Breast Cancer|May 25, 2021
Anti-tumor effects of an ID antagonist with no observed acquired resistancePaulina M Wojnarowicz, Marta Garcia Escolano, Yun-Han Huang, et al.
Pageof 1